Australia’s Mesoblast posts narrower quarterly loss, rise in R&D costs
CANBERRA: Australian regenerative medicine maker Mesoblast Ltd on Thursday posted a narrower quarterly loss but booked a rise in research ...
Tag: rise in R&D costs
Popular Stories
-
ATIR overturns actions taken by revenue athorities
-
FBR introduces SMS service 9966 to facilitate taxpayers
-
South African model nabbed for smuggling cocaine at Manila airport
-
Rs25,000/hour fare: Pakistan’s first helicopter tour service launched in Karachi
-
PM Shehbaz directs FBR to defer implementation of SRO 350